Tyagarajan Seshu
SEC insider (Form 3/4/5 filer). CIK 0001923794. Chief Technology Officer at Candel Therapeutics, Inc. (CADL). 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in NEEDHAM, MA.
Companies Tyagarajan Seshu has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Officer, Chief Technology Officer
Tyagarajan Seshu
CIK: 0001923794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Candel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 17, 2026CADL
Candel Therapeutics, Inc.
SaleDirect7K shares at avg. $12.00$84K - Jun 29, 2026CADL
Candel Therapeutics, Inc.
SaleDirect7K shares at avg. $10.02$70K - Jan 26, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
154K shares- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardDirect5.4K shares at avg. $4.67$25K - Mar 17, 2025CADL
Candel Therapeutics, Inc.
SaleDirect31.3K shares at avg. $8.82$276K - Mar 17, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect20K shares at avg. $1.29$26K - Feb 12, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Jan 15, 2025CADL
Candel Therapeutics, Inc.
SaleDirect14.3K shares at avg. $7.22$103K - Jan 8, 2025CADL
Candel Therapeutics, Inc.
SaleDirect14.5K shares at avg. $8.22$120K - Nov 29, 2024CADL
Candel Therapeutics, Inc.
SaleDirect20.4K shares at avg. $4.56$93K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 | CADL Candel Therapeutics, Inc. | Sale | 7,000 | $12.00 | $84,000 | Direct |
| Jun 29, 2026 | CADL Candel Therapeutics, Inc. | Sale | 7,000 | $10.02 | $70,151 | Direct |
| Jan 26, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 154,000 | - | - | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award | 5,353 | $4.67 | $24,999 | Direct |
| Mar 17, 2025 | CADL Candel Therapeutics, Inc. | Sale | 31,278 | $8.82 | $275,947 | Direct |
| Mar 17, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 20,000 | $1.29 | $25,800 | Direct |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Sale | 14,322 | $7.22 | $103,476 | Direct |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Sale | 14,545 | $8.22 | $119,534 | Direct |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Sale | 20,392 | $4.56 | $92,898 | Direct |
1-10 of 10 transactions